Rural seniors with dementia have longer nursing home stays, study finds
By
Alicia Lasek
Oct 23, 2020
Rural Medicare recipients with Alzheimer’s and related dementias have longer nursing home stays and shorter survival time following diagnosis than their urban peers, investigators say.
Amyloid brain plaques not a sure sign of Alzheimer’s, researchers find
By
Alicia Lasek
Jan 12, 2023
A new study challenges the theory that an increase in brain amyloid protein signals Alzheimer’s disease. The findings may be especially relevant to clinicians as amyloid-targeting drugs such as Leqembi...
FDA advisers vote ‘no’ on drug that may slow Alzheimer’s progression
By
Alicia Lasek
Nov 09, 2020
If approved by the FDA, aducanumab would be the first-ever drug marketed to slow progression of the brain-wasting disease, according to its developer. But an advisory committee was unconvinced of the drug’s...
Exercise may keep mild cognitive impairment from advancing to dementia
By
Alicia Lasek
Nov 13, 2020
Study participants who began a weekly exercise routine after diagnosis with MCI had an 11% lower risk of progressing to Alzheimer’s when compared with people who did not exercise at all, a new study...
Alzheimer’s drug gets FDA support ahead of Friday vote on approval
By
Alicia Lasek
Nov 05, 2020
Documents released on Wednesday show that the agency’s staff members already are enthusiastic about the drug’s prospects. If approved, aducanumab could be the first drug on the market to slow Alzheimer’s...
COVID-19 connected to dementia-like disability, multiple studies find
By
Alicia Lasek
Jul 27, 2021
A bout with COVID-19 can cause dementia-like brain changes and related functional decline, especially for seniors and in people who lose their sense of smell, researchers are finding.
Eli Lilly aims for dementia drug candidate’s approval in 2022; wants to ‘prioritize access’
By
Alicia Lasek
Aug 04, 2021
The Alzheimer’s disease-modifying drug donanemab is on track to be considered for full FDA approval by 2022, its developer said.
Falls may be an Alzheimer’s precursor, study finds
By
Alicia Lasek
Oct 14, 2020
Early brain changes may be the culprit when an older person with no signs of cognitive decline has a fall, researchers say. Such falls tend to occur about five years before memory loss and confusion arise.
Criticism, confusion and hope: new Alzheimer’s drug receives messy welcome
By
Alicia Lasek
Jun 15, 2021
Clinicians’ responses to the controversial approval of Aduhelm range between excitement and disapproval, with questions abounding on how to advise patients on treatment and the cost to patients and...